| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology [L. R. B., N. R., F. F. P.] and Preventive Medicine and Biostatistics [W. D. D.], Vanderbilt University, Nashville, Tennessee 37232
A key enzyme involved in the production of potentially carcinogenic estrogen metabolites and the activation of environmental carcinogens is cytochrome P450 1B1 (CYP1B1), the predominant member of the CYP1 family expressed in normal breast tissue and breast cancer. Because of the preeminent role of CYP1B1 in mammary estrogen/carcinogen metabolism, we examined the CYP1B1 gene to determine whether genetic differences could account for interindividual differences in breast cancer risk. We focused on exon 3, because it encodes the catalytically important heme binding domain of the enzyme, and discovered three polymorphisms of which two are associated with amino acid substitutions in codons 432 (Val
Leu) and 453 (AsnSer), designated as m1 and m2, respectively. Approximately 40% of Caucasian women have the m1 Val allele compared with nearly 70% of African-American women (P < 0.0001). The allele frequency also differs significantly in m2, with the rare Ser allele being present in 17.4% of Caucasians but only in 3.4% of African Americans (P < 0.0003). To determine whether the polymorphic CYP1B1 alleles hold implications as potential breast cancer risk factors, we compared the CYP1B1 genotypes in 164 Caucasian and 59 African-American breast cancer cases with those in age-, race-, and frequency-matched controls. Odds ratio calculations failed to show a significant association between any of the genotypes and breast cancer. Because CYP1B1 is known to be involved in mammary estrogen metabolism, we investigated whether the estrogen receptor status is influenced by the CYP1B1 genotypes. Caucasian patients with the m1 Val/Val genotype have a significantly higher percentage of estrogen receptor-positive (P = 0.02) and progesterone receptor-positive breast cancers (P = 0.003). There was no correlation with the m2 genotypes. These data suggest that the CYP1B1 polymorphisms in exon 3 are not associated with increased breast cancer risk but that the m1 polymorphism may be functionally important for steroid receptor expression in breast cancer of Caucasian patients.
1 Supported in part by United States Army Breast Cancer Training Grant DAMD-17-94-J4024 (to L. R. B.), National Cancer Institute Grants CA50468-06 and CA68485 (to W. D. D.), and NIH P30 ES00267 (to F. F. P.).
2 To whom requests for reprints should be addressed, at Department of Pathology, TVC 4918, Vanderbilt University Medical Center, Nashville, TN 37232. Phone: (615) 343-9117; Fax: (615) 343-9563.
Received 6/19/98. Accepted 9/28/98.
This article has been cited by other articles:
|
|
 |
|
  S. Helmig, B. Hadzaad, J. Dohrel, and J. Schneider Influence of the Cyp1B1 L432V Gene Polymorphism and Exposure to Tobacco Smoke on Cyp1B1 mRNA Expression in Human Leukocytes Drug Metab. Dispos., July 1, 2009; 37(7): 1490 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Timofeeva, S. Kropp, W. Sauter, L. Beckmann, A. Rosenberger, T. Illig, B. Jager, K. Mittelstrass, H. Dienemann, The LUCY-Consortium, et al. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences Carcinogenesis, July 1, 2009; 30(7): 1161 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. FONTANA, L. DELORT, L. JOUMARD, N. RABIAU, R. BOSVIEL, S. SATIH, L. GUY, J.-P. BOITEUX, Y.-J. BIGNON, A. CHAMOUX, et al. Genetic Polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 Genes and Association with Bladder Cancer Risk in a French Cohort Anticancer Res, May 1, 2009; 29(5): 1631 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. B. Okey, and P. A. Harper Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3098 - 3107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Diergaarde, J. D. Potter, E. R. Jupe, S. Manjeshwar, C. D. Shimasaki, T. W. Pugh, D. C. DeFreese, B. A. Gramling, I. Evans, and E. White Polymorphisms in Genes Involved in Sex Hormone Metabolism, Estrogen Plus Progestin Hormone Therapy Use, and Risk of Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1751 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Duell, P. M. Bracci, J. H. Moore, R. D. Burk, K. T. Kelsey, and E. A. Holly Detecting Pathway-Based Gene-Gene and Gene-Environment Interactions in Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1470 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Vineis, F Veglia, S Garte, C Malaveille, G Matullo, A Dunning, M Peluso, L Airoldi, K Overvad, O Raaschou-Nielsen, et al. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers Ann. Onc., July 1, 2007; 18(7): 1230 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Nock, D. Tang, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, K. G. Monaghan, A. Koprowski, N. Mitrache, J. J. Yang, et al. Associations between Smoking, Polymorphisms in Polycyclic Aromatic Hydrocarbon (PAH) Metabolism and Conjugation Genes and PAH-DNA Adducts in Prostate Tumors Differ by Race Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Paracchini, S. Raimondi, I. T. Gram, D. Kang, N. A. Kocabas, V. N. Kristensen, D. Li, F. F. Parl, T. Rylander-Rudqvist, P. Soucek, et al. Meta- and Pooled Analyses of the Cytochrome P-450 1B1 Val432Leu Polymorphism and Breast Cancer: A HuGE-GSEC Review Am. J. Epidemiol., January 15, 2007; 165(2): 115 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Tao, Q. Cai, W. H. Xu, N. Kataoka, W. Wen, W. Zheng, Y. B. Xiang, Z.-F. Zhang, and X. O. Shu Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Endometrial Cancer Risk in Chinese Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2570 - 2573. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. Okey, and P. Harper Dietary Phytoestrogen Intake Is Associated with Reduced Colorectal Cancer Risk J. Nutr., December 1, 2006; 136(12): 3046 - 3053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Crooke, M. D. Ritchie, D. L. Hachey, S. Dawling, N. Roodi, and F. F. Parl Estrogens, enzyme variants, and breast cancer: a risk model. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1620 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. De Roos, N. Rothman, M. Brown, D. A. Bell, G. S. Pittman, W. R. Shapiro, R. G. Selker, H. A. Fine, P. M. Black, and P. D. Inskip Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro-oncol, April 1, 2006; 8(2): 145 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Sissung, D. K. Price, A. Sparreboom, and W. D. Figg Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention Mol. Cancer Res., March 1, 2006; 4(3): 135 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Sellers, J. M. Schildkraut, V. S. Pankratz, R. A. Vierkant, Z. S. Fredericksen, J. E. Olson, J. Cunningham, W. Taylor, M. Liebow, C. McPherson, et al. Estrogen Bioactivation, Genetic Polymorphisms, and Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2536 - 2543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Cicek, X. Liu, G. Casey, and J. S. Witte Role of Androgen Metabolism Genes CYP1B1, PSA/KLK3, and CYP11{alpha} in Prostate Cancer Risk and Aggressiveness Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2173 - 2177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Canter, A. R. Kallianpur, F. F. Parl, and R. C. Millikan Mitochondrial DNA G10398A Polymorphism and Invasive Breast Cancer in African-American Women Cancer Res., September 1, 2005; 65(17): 8028 - 8033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Le Marchand, T. Donlon, L. N. Kolonel, B. E. Henderson, and L. R. Wilkens Estrogen Metabolism-Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1998 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Aklillu, S. Ovrebo, I. V. Botnen, C. Otter, and M. Ingelman-Sundberg Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[a]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[a]pyrene Cancer Res., June 15, 2005; 65(12): 5105 - 5111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. M. van Duursen, J. T. Sanderson, and M. van den Berg Cytochrome P450 1A1 and 1B1 in Human Blood Lymphocytes Are Not Suitable as Biomarkers of Exposure to Dioxin-like Compounds: Polymorphisms and Interindividual Variation in Expression and Inducibility Toxicol. Sci., May 1, 2005; 85(1): 703 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wen, Q. Cai, X.-O. Shu, J.-R. Cheng, F. Parl, L. Pierce, Y.-T. Gao, and W. Zheng Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 329 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bandiera, S. Weidlich, V. Harth, P. Broede, Y. Ko, and T. Friedberg Proteasomal Degradation of Human CYP1B1: Effect of the Asn453Ser Polymorphism on the Post-Translational Regulation of CYP1B1 Expression Mol. Pharmacol., February 1, 2005; 67(2): 435 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rylander-Rudqvist, S. Wedren, G. Jonasdottir, S. Ahlberg, E. Weiderpass, I. Persson, and M. Ingelman-Sundberg Cytochrome P450 1B1 Gene Polymorphisms and Postmenopausal Endometrial Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1515 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. McGrath, S. E. Hankinson, L. Arbeitman, G. A. Colditz, D. J. Hunter, and I. De Vivo Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility Carcinogenesis, April 1, 2004; 25(4): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sasaki, Y. Tanaka, S. T. Okino, M. Nomoto, S. Yonezawa, M. Nakagawa, S. Fujimoto, N. Sakuragi, and R. Dahiya Polymorphisms of the CYP1B1 Gene as Risk Factors for Human Renal Cell Cancer Clin. Cancer Res., March 15, 2004; 10(6): 2015 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Tworoger, J. Chubak, E. J. Aiello, C. M. Ulrich, C. Atkinson, J. D. Potter, Y. Yasui, P. L. Stapleton, J. W. Lampe, F. M. Farin, et al. Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 94 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhu, P. Chang, M. L. Bondy, A. A. Sahin, S. E. Singletary, S. Takahashi, T. Shirai, and D. Li Detection of 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]-Pyridine-DNA Adducts in Normal Breast Tissues and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 830 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rylander-Rudqvist, S. Wedren, F. Granath, K. Humphreys, S. Ahlberg, E. Weiderpass, M. Oscarson, M. Ingelman-Sundberg, and I. Persson Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk Carcinogenesis, September 1, 2003; 24(9): 1533 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sasaki, Y. Tanaka, M. Kaneuchi, N. Sakuragi, and R. Dahiya CYP1B1 Gene Polymorphisms Have Higher Risk for Endometrial Cancer, and Positive Correlations with Estrogen Receptor {alpha} and Estrogen Receptor {beta} Expressions Cancer Res., July 15, 2003; 63(14): 3913 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Mammen, G. S. Pittman, Y. Li, F. Abou-Zahr, B. A. Bejjani, D. A. Bell, P. T. Strickland, and T. R. Sutter Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans-7,8-dihydrodiol Carcinogenesis, July 1, 2003; 24(7): 1247 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gibson, J. H. Gill, P. A. Khan, J. M. Seargent, S. W. Martin, P. A. Batman, J. Griffith, C. Bradley, J. A. Double, M. C. Bibby, et al. Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development Mol. Cancer Ther., June 1, 2003; 2(6): 527 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, F. L. Walcott, P. Chang, W. Zhang, J. Zhu, E. Petrulis, S. E. Singletary, A. A. Sahin, and M. L. Bondy Genetic and Environmental Determinants on Tissue Response to in Vitro Carcinogen Exposure and Risk of Breast Cancer Cancer Res., August 15, 2002; 62(16): 4566 - 4570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. De Vivo, S. E. Hankinson, L. Li, G. A. Colditz, and D. J. Hunter Association of CYP1B1 Polymorphisms and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 489 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Aklillu, M. Oscarson, M. Hidestrand, B. Leidvik, C. Otter, and M. Ingelman-Sundberg Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population Mol. Pharmacol., March 1, 2002; 61(3): 586 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Powell, I. L. van Staveren, P. Roosken, F. Grieu, E. M.J.J. Berns, and B. Iacopetta Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer Carcinogenesis, February 1, 2002; 23(2): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ko, J. Abel, V. Harth, P. Brode, C. Antony, S. Donat, H.-P. Fischer, M. E. Ortiz-Pallardo, R. Thier, A. Sachinidis, et al. Association of CYP1B1 Codon 432 Mutant Allele in Head and Neck Squamous Cell Cancer Is Reflected by Somatic Mutations of p53 in Tumor Tissue Cancer Res., June 1, 2001; 61(11): 4398 - 4404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Goodman, K. McDuffie, L. N. Kolonel, K. Terada, T. A. Donlon, L. R. Wilkens, C. Guo, and L. Le Marchand Case-Control Study of Ovarian Cancer and Polymorphisms in Genes Involved in Catecholestrogen Formation and Metabolism Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 209 - 216. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Williams and D. H. Phillips Mammary Expression of Xenobiotic Metabolizing Enzymes and Their Potential Role in Breast Cancer Cancer Res., September 1, 2000; 60(17): 4667 - 4677. [Abstract] [Full Text]
|
|
|
|
|
|
F. P. Guengerich Metabolism of chemical carcinogens Carcinogenesis, March 1, 2000; 21(3): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Bejjani, D. W. Stockton, R. A. Lewis, K. F. Tomey, D. K. Dueker, M. Jabak, W. F. Astle, and J. R. Lupski Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus Hum. Mol. Genet., February 12, 2000; 9(3): 367 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zheng, D.-W. Xie, F. Jin, J.-R. Cheng, Q. Dai, W.-Q. Wen, X.-O. Shu, and Y.-T. Gao Genetic Polymorphism of Cytochrome P450-1B1 and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 147 - 150. [Abstract] [Full Text]
|
|
|
|
|
|
C. Guillemette, R. C. Millikan, B. Newman, and D. E. Housman Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans Cancer Res., February 1, 2000; 60(4): 950 - 956. [Abstract] [Full Text]
|
|
|
|
|
|
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. C.E. McFadyen, S. Breeman, S. Payne, C. Stirk, I. D. Miller, W. T. Melvin, and G. I. Murray Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1 J. Histochem. Cytochem., November 1, 1999; 47(11): 1457 - 1464. [Abstract] [Full Text]
|
|
|
|
|
|
T. Shimada, J. Watanabe, K. Kawajiri, T. R. Sutter, F. P. Guengerich, E. M.J. Gillam, and K. Inoue Catalytic properties of polymorphic human cytochrome P450 1B1 variants Carcinogenesis, August 1, 1999; 20(8): 1607 - 1614. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
